Literature DB >> 19147458

Effects of global longitudinal strain and total scar burden on response to cardiac resynchronization therapy in patients with ischaemic dilated cardiomyopathy.

Antonello D'Andrea1, Pio Caso, Raffaella Scarafile, Lucia Riegler, Gemma Salerno, Francesca Castaldo, Rita Gravino, Rosangela Cocchia, Luca Del Viscovo, Giuseppe Limongelli, Giovanni Di Salvo, Luigi Ascione, Raffaele Iengo, Sergio Cuomo, Lucio Santangelo, Raffaele Calabrò.   

Abstract

AIMS: To evaluate whether quantification of the extent of scarred left ventricular (LV) tissue by speckle-tracking strain echo (2DSE) can predict response to cardiac resynchronization therapy (CRT) in patients with ischaemic dilated cardiomyopathy (DCM). METHODS AND
RESULTS: Forty-five patients (58.3 +/- 8.3 years; 24 males) with ischaemic DCM scheduled for CRT, and 25 controls were studied. A week before implantation all the patients underwent standard Doppler echo, 2DSE, and contrast-enhanced magnetic resonance (MR). Clinical and echocardiographic evaluation was repeated 6 months after CRT. The patients were considered as responders to CRT if LV end-systolic volume decreased by 15%. In DCM patients, LV ejection fraction was 29.2 +/- 5.1%. By evaluating the 765 segments with MR, subendocardial infarct was identified in 17.0% and transmural infarct in 18.3%. With 2DSE, the average global longitudinal strain (GLS) was -23.1 +/- 3.6% in controls and -15.1 +/- 5.1% in DCM (P = 0.001). GLS showed a close correlation with total scar burden using MR (r = 0.64, P < 0.001). At follow-up, patients were subdivided into responders (n = 30; 66.7%) and non-responders (n = 15; 33.3%) to CRT. GLS was significantly different in non-responders than in responders (GLS: -10.4 +/- 5.1 in non-responders vs. -18.4 +/- 14% in responders, P < 0.001). In a multivariable analysis, GLS (P < 0.0001) and radial intraventricular dyssynchrony (P < 0.001) were powerful independent determinants of response to CRT.
CONCLUSION: GLS is strongly associated with total scar burden assessed by MR, and is an excellent independent predictor of response to CRT.

Entities:  

Mesh:

Year:  2009        PMID: 19147458     DOI: 10.1093/eurjhf/hfn010

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  14 in total

Review 1.  Current role of echocardiography in cardiac resynchronization therapy.

Authors:  Donato Mele; Matteo Bertini; Michele Malagù; Marianna Nardozza; Roberto Ferrari
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

2.  Baseline asynchrony, assessed circumferentially using temporal uniformity of strain, besides coincidence between site of latest mechanical activation and presumed left ventricular lead position, predicts favourable prognosis after resynchronization therapy.

Authors:  Chiara Cavallino; Elisa Rondano; Andrea Magnani; Lucia Leva; Eugenio Inglese; Gabriele Dell'era; Eraldo Occhetta; Miriam Bortnik; Paolo N Marino
Journal:  Int J Cardiovasc Imaging       Date:  2011-06-19       Impact factor: 2.357

Review 3.  Longitudinal and circumferential strain in patients with regional LV dysfunction.

Authors:  Manish Bansal; Partho P Sengupta
Journal:  Curr Cardiol Rep       Date:  2013-03       Impact factor: 2.931

Review 4.  Cardiac sympathetic innervation and cardiac resynchronization therapy.

Authors:  A M Scholtens; A J A T Braat; A Tuinenburg; M Meine; H J Verberne
Journal:  Heart Fail Rev       Date:  2014-09       Impact factor: 4.214

5.  Effect of cardiac resynchronization therapy on cardiotrophin-1 circulating levels in patients with heart failure.

Authors:  Giuseppe Limongelli; Teo Roselli; Giuseppe Pacileo; Paolo Calabró; Valeria Maddaloni; Daniele Masarone; Lucia Riegler; Rita Gravino; Raffaella Scarafile; Gemma Salerno; Tiziana Miele; Antonello D'Andrea; Lucio Santangelo; Massimo Romano; Giovanni Di Salvo; Maria Giovanna Russo; Raffaele Calabró
Journal:  Intern Emerg Med       Date:  2011-12-17       Impact factor: 3.397

Review 6.  Global longitudinal strain predicts responders after cardiac resynchronization therapy-a systematic review and meta-analysis.

Authors:  George Bazoukis; Costas Thomopoulos; Gary Tse; Konstantinos Tsioufis; Petros Nihoyannopoulos
Journal:  Heart Fail Rev       Date:  2021-03-30       Impact factor: 4.214

Review 7.  The role of cardiac magnetic resonance in identifying appropriate candidates for cardiac resynchronization therapy - a systematic review of the literature.

Authors:  George Bazoukis; Jeremy Man Ho Hui; Yan Hiu Athena Lee; Oscar Hou In Chou; Dimitrios Sfairopoulos; Konstantinos Vlachos; Athanasios Saplaouras; Konstantinos P Letsas; Michael Efremidis; Gary Tse; Vassilios S Vassiliou; Panagiotis Korantzopoulos
Journal:  Heart Fail Rev       Date:  2022-08-31       Impact factor: 4.654

Review 8.  Speckle tracking echocardiography: clinical applications in cardiac resynchronization therapy.

Authors:  Xiaoshan Zhang; Si Ha; Xiaolei Wang; Yilu Shi; Shasha Duan; Zhian Li
Journal:  Int J Clin Exp Med       Date:  2015-05-15

9.  Outcomes of cardiac resynchronization therapy in patients with chemotherapy-induced cardiomyopathy.

Authors:  Fatima M Ezzeddine; Antoine N Saliba; Vaibhav Jain; Hector R Villarraga; Joerg Herrmann; Samuel J Asirvatham; Yong-Mei Cha
Journal:  Pacing Clin Electrophysiol       Date:  2021-03-15       Impact factor: 1.976

10.  Evidence of scar tissue: contra-indication to cardiac resynchronization therapy?

Authors:  E E van der Wall; M J Schalij; H F Verwey; J J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2010-07-08       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.